(Rac)-Bendroflumethiazide-d5

• CAT Number: S000263
• CAS Number: 1330183-13-5
• Molecular Formula: C15H9D5F3N3O4S2
• Molecular Weight: 426.45
• Purity: ≥95%
• IUPAC Name: 1,1-dioxo-3-[(2,3,4,5,6-pentadeuteriophenyl)methyl]-6-(trifluoromethyl)-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide
• InChI: InChI=1S/C15H14F3N3O4S2/c16-15(17,18)10-7-11-13(8-12(10)26(19,22)23)27(24,25)21-14(20-11)6-9-4-2-1-3-5-9/h1-5,7-8,14,20-21H,6H2,(H2,19,22,23)/i1D,2D,3D,4D,5D
• InChIKey: HDWIHXWEUNVBIY-RALIUCGRSA-N
• SMILES: [2H]C1=C(C(=C(C(=C1[2H])[2H])CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2)[2H])[2H]

(Rac)-Bendroflumethiazide-d5 (CAS: 1330183-13-5), a premium pharmaceutical research compound designed for advanced diuretic and antihypertensive studies. As a deuterated analog of Bendroflumethiazide, it offers enhanced stability and improved pharmacokinetic properties. (Rac)-Bendroflumethiazide-d5 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel diuretic and blood pressure regulation therapies. Trusted by leading laboratories, (Rac)-Bendroflumethiazide-d5 is your go-to solution for cutting-edge cardiovascular research. Unlock new possibilities in hypertension treatment with (Rac)-Bendroflumethiazide-d5, where innovation meets reliability.

Reference

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
[Content Brief]